Induced pluripotent stem (iPS) cell-based cell therapy for muscular dystrophy: Current progress and future prospects

Brain and Nerve

Volumn 64, Issue 1, 2012, Pages 39-46

  Nishiyama, Takashi ^a,b   Takeda, Shin'ichi ^a,b  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

Author keywords

Duchenne muscular dystrophy; Dystrophin; Myoblasts; Pax3; Reprogramming; Skeletal muscle

Indexed keywords

TRANSCRIPTION FACTOR PAX3; TRANSCRIPTION FACTOR PAX7;

ARTICLE; DUCHENNE MUSCULAR DYSTROPHY; NONHUMAN; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; STEM CELL TRANSPLANTATION; ANIMAL; DISEASE MODEL; FORECASTING; HUMAN; MOUSE; MUSCULAR DYSTROPHY; REGENERATIVE MEDICINE; REVIEW; TRANSPLANTATION;

ANIMALS; DISEASE MODELS, ANIMAL; FORECASTING; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICE; MUSCULAR DYSTROPHIES; REGENERATIVE MEDICINE;

EID: 84859412643     PISSN: 18816096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Miyagoe-Suzuki Y, Takeda S: Gene therapy for muscle disease. Exp Cell Res 316: 3087-3092, 2010
2. Wagner KR, Fleckenstein JL, Amato AA, Barohn RJ, Bushby K, et al: A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy. Ann Neurol 63: 561-571, 2008
3. Fukada S, Yamaguchi M, Kokubo H, Ogawa R, Uezumi A, et al: Hesr1 and Hesr3 are essential to generate undifferentiated quiescent satellite cells and to maintain satellite cell numbers. Development 138: 4609-4619, 2011
4. Mouly V, Aamiri A, Perie S, Mamchaoui K, Barani A, et al: Myoblast transfer therapy: is there any light at the end of the tunnel? Acta Myol 24: 128-133, 2005 (Pubitemid 43287350)
5. Collins CA, Olsen I, Zammit PS, Heslop L, Petrie A, et al: Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche. Cell 122: 289-301, 2005 (Pubitemid 41032991)
6. Minasi MG, Riminucci M, De Angelis L, Borello U, Berarducci B, et al: The meso-angioblast: a multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues. Development 129: 2773-2783, 2002 (Pubitemid 34874259)
7. Sampaolesi M, Torrente Y, Innocenzi A, Tonlorenzi R, D'Antona G, et al: Cell therapy of alpha-sarcoglycan null dystrophic mice through intraarterial delivery of mesoangioblasts. Science 301: 487-492, 2003 (Pubitemid 36900300)
8. Sampaolesi M, Blot S, D'Antona G, Granger N, Tonlorenzi R, et al: Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 444: 574-579, 2006 (Pubitemid 44864430)
9. Dellavalle A, Sampaolesi M, Tonlorenzi R, Tagliafico E, Sacchetti B, et al: Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nat Cell Biol 9: 255-267, 2007 (Pubitemid 46349927)
10. De Angelis L, Berghella L, Coletta M, Lattanzi L, Zanchi M, et al: Skeletal myogenic progenitors originating from embryonic dorsal aorta coexpress endothelial and myogenic markers and contribute to postnatal muscle growth and regeneration. J Cell Biol 147: 869-878, 1999
11. Takahashi K, Yamanaka S: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676, 2006 (Pubitemid 44233629)
12. Takahashi K, Okita K, Nakagawa M, Yamanaka S: Induction of pluripotent stem cells from fibroblast cultures. Nat Protoc 2: 3081-3089, 2007
13. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, et al: Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920, 2007
14. Mauro A: Satellite cell of skeletal muscle fibers. J Biophys Bioc hem Cytol 9: 493-495, 1961
15. Park IH, Arora N, Huo H, Maherali N, Ahfeldt T, et al: Disease-specific induced pluripotent stem cells. Cell 134: 877-886, 2008
16. Darabi R, Gehlbach K, Bachoo RM, Kamath S, Osawa M, et al: Functional skeletal muscle regeneration from differentiating embryonic stem cells. Nat Med 14: 134-143, 2008 (Pubitemid 351214552)
17. Darabi R, Santos FN, Filareto A, Pan W, Koene R, et al: Assessment of the myogenic stem cell compartment following transplantation of Pax3/Pax7-induced embryonic stem cell-derived progenitors. Stem Cells 29: 777-790, 2011
18. Chang H, Yoshimoto M, Umeda K, Iwasa T, Mizuno Y, et al: Generation of transplantable, functional satellite-like cells from mouse embryonic stem cells. FASEB J 23: 1907-1919, 2009
19. Mizuno Y, Chang H, Umeda K, Niwa A, Iwasa T, et al: Generation of skeletal muscle stem/progenitor cells from murine induced pluripotent stem cells. FASEB J 24: 2245-2253, 2010
20. Sakurai H, Inami Y, Tamamura Y, Yoshikai T, Sehara-Fujisawa A, et al: Bidirectional induction toward paraxial mesodermal derivatives from mouse ES cells in chemically defined medium. Stem Cell Res 3: 157-169, 2009
21. Sakurai H, Okawa Y, Inami Y, Nishio N, Isobe K: Paraxial mesodermal progenitors derived from mouse embryonic stem cells contribute to muscle regeneration via differentiation into muscle satellite cells. Stem Cells 26: 1865-1873, 2008
22. Sakamoto M, Yuasa K, Yoshimura M, Yokota T, Ikemoto T, et al: Micro-dystrophin cDNA ameliorates dystrophic phenotypes when introduced into mdx mice as a transgene. Biochem Biophys Res Commun 293: 1265-1272, 2002 (Pubitemid 34681078)
23. Yoshimura M, Sakamoto M, Ikemoto M, Mochizuki Y, Yuasa K, et al: AAV vector-mediated microdystrophin expression in a relatively small percentage of mdx myofibers improved the mdx phenotype. Mol Ther 10: 821-828, 2004 (Pubitemid 39419909)
24. Hoshiya H, Kazuki Y, Abe S, Takiguchi M, Kajitani N, et al: A highly stable and nonintegrated human artificial chromosome (HAC) containing the 2.4 Mb entire human dystrophin gene. Mol Ther 17: 309-317, 2009
25. Hiramatsu K, Sasagawa S, Outani H, Nakagawa K, Yoshikawa H, et al: Generation of hyaline cartilaginous tissue from mouse adult dermal fibroblast culture by defined factors. J Clin Invest 121: 640-657, 2011
26. Sekiya S, Suzuki A: Direct conversion of mouse fibroblasts to hepatocyte-like cells by defined factors. Nature 475: 390-393, 2011
27. Weintraub H, Tapscott SJ, Davis RL, Thayer MJ, Adam MA, et al: Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. Proc Natl Acad Sci U S A 86: 5434-5438, 1989 (Pubitemid 19185563)
28. Kimura E, Han JJ, Li S, Fall B, Ra J, et al: Cell-lineage regulated myogenesis for dystrophin replacement: a novel therapeutic approach for treatment of muscular dystrophy. Hum Mol Genet 17: 2507-2517, 2008
29. Segawa M, Fukada S, Yamamoto Y, Yahagi H, Kanematsu M, et al: Suppression of macrophage functions impairs skeletal muscle regeneration with severe fibrosis. Exp Cell Res 314: 3232-3244, 2008
30. Tidball JG, Villalta SA: Regulatory interactions between muscle and the immune system during muscle regeneration. Am J Physiol Regul Integr Comp Physiol 298: R1173-1187, 2010
31. Motohashi N, Uezumi A, Yada E, Fukada S, Fukushima K, et al: Muscle CD31 (-) CD45 (-) side population cells promote muscle regeneration by stimulating proliferation and migration of myoblasts. Am J Pathol 173: 781-791, 2008
32. Uezumi A, Fukada S, Yamamoto N, Takeda S, Tsuchida K: Mesenchymal progenitors distinct from satellite cells contribute to ectopic fat cell formation in skeletal muscle. Nat Cell Biol 12: 143-152, 2010
33. Joe AW, Yi L, Natarajan A, Le Grand F, So L, et al: Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis. Nat Cell Biol 12: 153-163, 2010